A Prospective Descriptive Study Evaluating the Impact of Clinical Pharmacists on Inpatient Addiction Services Qualitatively Assessed Through Patient-Reported Outcomes

Background:Located at the Peter Lougheed Centre in Calgary, Alberta, the Addiction Recovery Community Health (ARCH) team is a unique multidisciplinary inpatient consult service that is supported by a clinical pharmacist. By quantifying and describing the interventions provided by ARCH pharmacists, this study provides an extensive analysis of the clinical services that pharmacists can offer patients experiencing substance use disorder (SUD).Objective:(1) To describe and quantify the types of interventions provided by ARCH pharmacists related to pharmacotherapy for alcohol use disorder (AUD) and opioid use disorder (OUD). (2) To assess patient perspectives on the involvement and contributions of the ARCH pharmacist on the care they receive while in the hospital.Methods:This was a prospective descriptive study conducted between June 2021 and December 2022. Demographic and intervention data was collected from ARCH pharmacist progress notes and classified accordingly. Upon discharge, an optional survey was provided to capture patient perspectives on the care they received from ARCH pharmacists.Results:A total of 50 patients (54% male) were included in the study. The mean +/- SD age of patients was 43.96 +/- 12.9 y. Most patients presented with OUD compared with AUD (66% vs. 26%). Overall, 293 interventions were identified, with follow-up and monitoring (36%) being the most common and Naloxone kit and training (1%) being the least common. Medication prescribed or recommended (17%) included the initiation of therapies such as acamprosate, naltrexone, and extended-release buprenorphine injection. Survey results demonstrated that patients had overwhelmingly positive experiences with ARCH pharmacists involved in their care.Conclusions:Beyond simply treatment initiation, pharmacists have the opportunity to become involved in many aspects of care in patients with SUD. Contexte:Situ & eacute;e au Peter Lougheed Centre de Calgary, en Alberta, l'& eacute;quipe Addiction Recovery Community Health (ARCH) est un service de consultation multidisciplinaire unique pour les patients hospitalis & eacute;s, qui b & eacute;n & eacute;ficie du soutien d'un pharmacien clinicien. En quantifiant et en d & eacute;crivant les interventions des pharmaciens de l'& eacute;quipe ARCH, cette & eacute;tude fournit une analyse approfondie des services cliniques que les pharmaciens peuvent offrir aux patients souffrant de troubles li & eacute;s & agrave; l'utilisation de substances (TUS).Objectifs:(1). D & eacute;crire et quantifier les types d'interventions fournies par les pharmaciens de l'ARCH concernant la pharmacoth & eacute;rapie des troubles li & eacute;s & agrave; la consommation d'alcool (TCA) et des troubles li & eacute;s & agrave; la consommation d'opiac & eacute;s (TCO). (2). & Eacute;valuer le point de vue des patients sur l'implication et la contribution du pharmacien de l'ARCH dans les soins qu'ils re & ccedil;oivent & agrave; l'h & ocirc;pital.M & eacute;thodes:Il s'agit d'une & eacute;tude descriptive prospective men & eacute;e entre juin 2021 et d & eacute;cembre 2022. Les donn & eacute;es d & eacute;mographiques et d'intervention ont & eacute;t & eacute; recueillies & agrave; partir des notes d'& eacute;volution du pharmacien de l'ARCH et class & eacute;es en cons & eacute;quence (tableau 1). & Agrave; la sortie de l'h & ocirc;pital, une enqu & ecirc;te facultative a & eacute;t & eacute; fournie pour recueillir le point de vue des patients sur les soins qu'ils ont re & ccedil;us des pharmaciens de l'ARCH.R & eacute;sultats:Au total, 50 patients (54% d'hommes) ont & eacute;t & eacute; inclus dans l'& eacute;tude. L'& acirc;ge moyen +/- SD des patients & eacute;tait de 43,96 +/- 12,9 ans. La plupart des patients pr & eacute;sentaient des TCO par rapport aux TCA (66% vs 26%). Dans l'ensemble, 293 interventions ont & eacute;t & eacute; identifi & eacute;es, le suivi et la surveillance (36%) & eacute;tant les plus courants et le kit de Naloxone et la formation (1%) & eacute;tant les moins courants. Les m & eacute;dicaments prescrits ou recommand & eacute;s (17%) comprenaient l'initiation de th & eacute;rapies telles que l'Acamprosate, la Naltrexone et la Bupr & eacute;norphine injectable & agrave; lib & eacute;ration prolong & eacute;e. Les r & eacute;sultats de l'enqu & ecirc;te ont montr & eacute; que les patients ont eu des exp & eacute;riences extr & ecirc;mement positives avec les pharmaciens de l'ARCH impliqu & eacute;s dans leurs soins.Conclusions:Au-del & agrave; de la simple initiation du traitement, les pharmaciens ont la possibilit & eacute; de s'impliquer dans de nombreux aspects des soins prodigu & eacute;s aux patients souffrant d'un TUS.